Vitrolife intends to carry out a directed share issue
Vitrolife AB (publ) (“Vitrolife”) has mandated Skandinaviska Enskilda Banken (“SEB”) to evaluate the conditions for carrying out a directed share issue corresponding to a value of approximately SEK 3.6 billion, through an accelerated book building procedure, based on the authorisation granted to the board of directors on the annual general meeting on 28 April 2021. The directed share issue is fully covered by subscription commitments from a number of current shareholders and new investors.Proceeds received from the directed share issue will be used to partly finance the acquisition of